We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+11.34%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$418M
AUM Growth
-$126M
Cap. Flow
-$156M
Cap. Flow %
-37.36%
Top 10 Hldgs %
4.96%
Holding
1,247
New
305
Increased
165
Reduced
252
Closed
519

Sector Composition

Rank Sector Weight
1 Healthcare 15.21%
2 Industrials 13.45%
3 Consumer Discretionary 13.43%
4 Technology 12.91%
5 Financials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
676
Agenus
AGEN
$254M
$83K 0.02%
+586
New +$67.2K
HDSN
677
Hudson Technologies
HDSN
$265M
$83K 0.02%
+12,433
New +$65.6K
CZZ
678
DELISTED
Cosan Limited
CZZ
$83K 0.02%
+11,543
New +$77.9K
LRMR icon
679
Larimar Therapeutics
LRMR
$398M
$82K 0.02%
2,062
+726
+54% +$33K
JNP
680
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$82K 0.02%
+14,707
New +$97.3K
CNV
681
DELISTED
CNOVA N.V.
CNV
$82K 0.02%
+15,310
New +$78.8K
DHT icon
682
DHT Holdings
DHT
$2.94B
$81K 0.02%
19,229
-95,541
-83% -$444K
DXYN
683
DELISTED
Dixie Group Inc
DXYN
$81K 0.02%
+16,139
New +$66.4K
ITI
684
DELISTED
Iteris, Inc.
ITI
$80K 0.02%
+22,105
New +$76.8K
WG
685
DELISTED
Willbros Group
WG
$80K 0.02%
42,411
-357,507
-89% -$733K
EXK
686
Endeavour Silver
EXK
$2.33B
$77K 0.02%
14,995
-3,825
-20% -$19.1K
CMBT
687
CMB.TECH NV
CMBT
$4.45B
$77K 0.02%
+10,074
New +$88.1K
NVTR
688
DELISTED
Nuvectra Corporation Common Stock
NVTR
$74K 0.02%
+10,725
New +$73.7K
DSCI
689
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$74K 0.02%
+15,860
New +$74K
AGRX
690
DELISTED
Agile Therapeutics
AGRX
$73K 0.02%
5
-6
-55% -$85.6K
LITS
691
Lite Strategy Inc
LITS
$33.3M
$71K 0.02%
+2,019
New +$67.9K
TGA
692
DELISTED
Transglobe Energy Corp
TGA
$71K 0.02%
36,162
-18,232
-34% -$33.4K
MRTX
693
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$70K 0.02%
+10,613
New +$56.5K
NE
694
DELISTED
Noble Corporation
NE
$68K 0.02%
+10,710
New +$72K
MFIC icon
695
MidCap Financial Investment
MFIC
$792M
$66K 0.02%
3,781
-1,998
-35% -$35K
ECYT
696
DELISTED
Endocyte, Inc. Common Stock
ECYT
$65K 0.02%
+20,974
New +$65.4K
MNTX
697
DELISTED
Manitex International, Inc.
MNTX
$65K 0.02%
+11,885
New +$75.7K
CORI
698
DELISTED
Corium International, Inc.
CORI
$64K 0.02%
11,379
-12,954
-53% -$65.1K
EVRI
699
DELISTED
Everi Holdings
EVRI
$63K 0.02%
25,615
-162,128
-86% -$322K
IEC
700
DELISTED
IEC Electronics Corp.
IEC
$61K 0.01%
+12,698
New +$62.2K

Similar funds

TFS Capital's Q3 2016 Portfolio in Review

As of Q3 2016, TFS Capital held 1,247 positions worth $418M, down 23% from $544M the previous quarter. Its ten largest holdings account for 5% of the portfolio.

TFS Capital withdrew a net $156M in Q3 2016, closing 519 positions and reducing 252 holdings. Its most notable exit was Cousins Properties, an estimated $2.63M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, TFS Capital opened a new position in Elme Communities worth $1.96M.

  • TFS Capital's largest Q3 2016 buy was Elme Communities: 62,841 shares worth $1.96M.
  • TFS Capital added most to ICU Medical in Q3 2016, an estimated $1.72M increase.
  • TFS Capital's biggest Q3 2016 reduction was A10 Networks, cutting an estimated $2.5M.
  • TFS Capital fully exited Cousins Properties in Q3 2016, selling an estimated $2.63M.
  • TFS Capital's ten largest holdings make up 5% of its $418M portfolio in Q3 2016.
  • TFS Capital opened 305 new positions and closed 519 in Q3 2016.
  • TFS Capital's portfolio value fell 23% quarter-over-quarter to $418M.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.